Cases & Deals

Astellas Pharma acquires Ogeda SA for €800 million (US$852 million)

Clients Astellas Pharma Inc.

Jones Day advised Astellas Pharma Inc., a Japanese leader in the pharma industry, in its €800 million (US$852 million) acquisition of Ogeda SA, a privately owned Belgian drug discovery company.

In addition to M&A representation, Jones Day provided antitrust and intellectual property advice regarding this transaction.